Comparing total health care costs and treatment patterns of HIV patients in a managed care setting

References

• Anis AH Hogg RS Wang XH et al Modeling the potential economic impact of viral load driven triple drug combination antiretroviral therapy Pharmacoeconomics 13 (6) 697 705 1998a
   PubMed Web of Science ®Google Scholar
• Anis AH Hogg RS Yip B et al Average annual drug cost and its determinants in a population-based cohort of HIV-positive men and women Pharmacoeconomics 13 (3) 327 336 1998b
   PubMed Web of Science ®Google Scholar
• Besch CL Morse E Simon P et al for the Terry Berin Community Programs for Clinical Research on AIDS 1997 Preliminary results of a compliance study within CPCRA 007 Combination Nucleoside Study (NuCombo) Paper presented at fourth National Conference on Retroviruses and Opportunistic Infections Washington DC 23 January
   Google Scholar
• Bonnet , E , Ruidavets , JB , Tuech , J , Ferrieres , J , Collet , X , Fauvel , J , Mawssip , P and Perrit , B . 2001 . Apoprotein c-III and E-containing lipoparticles are markedly increased in HIV-infected patients treated with protease inhibitors: association with the development of lipodystrophy . Journal of Clinical Endocrinology & Metabolism , 86 (1) : 296 – 302 .
   PubMed Web of Science ®Google Scholar
• Bozzette SA Berry SH Duan N et al The care of HIV-infected adults in the United States: HIV cost and services utilization consortium New England Journal of Medicine 339 (26) 1897 904 1998
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention . 1993 . Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults . Morbidity and Mortality Weekly Reports , 41 ( RR-17 )
   Google Scholar
• Centers for Disease Control and Prevention 1997 HIV/AIDS Surveillance Report 9 1 1 37
   Google Scholar
• Center for Disease Control and Prevention . 1998 . Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents . Morbidity and Mortality Weekly Reports , 47 ( RR-5 ) : 1 – 82 .
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention . 1999a . HIV/AIDS Surveillance Report , 11 ( 1 ) : 1 – 42 .
   Google Scholar
• Centers for Disease Control and Prevention . 2000 . HIV/AIDS Surveillance Report , 12 ( 2 ) : 1 – 41 .
   Google Scholar
• Clark , DO , Von Korff , M , Saunders , K , Baluch , WM and Simmon , GE . 1995 . A chronic disease score with empirically derived weights . Medical Care , 33 (8) : 783 – 795 .
   PubMed Web of Science ®Google Scholar
• Cody RP Smith JK 1997 Applied statistics and the SAS programming language 4th edition pp. 138–146 Upper Saddle River NJ Prentice Hall
   Google Scholar
• Crane L Crowe R Fine S et al Hospital and outpatient health services utilization among HIV-infected patients in care in 1999 Journal of Acquired Immune Deficiency Syndromes 30 (1) 21 26 2002
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services 1998 Guidelines for the use of antiretroviral agents in HIV infected adults and adolescents 17 June
   Google Scholar
• Farmer P Leandre F Mukherjee J et al Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy) Bulletin of the World Health Organization 79 (12) 1145 1151 2001
   PubMed Web of Science ®Google Scholar
• Garattini L Tediosi F Di Cintio E et al Resource utilization and hospital cost of HIV/AIDS care in Italy in the era of highly active antiretroviral therapy AIDS Care 13 (6) 733 741 2001
   PubMed Web of Science ®Google Scholar
• Keiser P Kvganli M Turner D et al 1998 Decreased hospital utilization and costs are associated with protease inhibitor therapy but not with nucleoside therapy 5th Conference on Retroviruses and Opportunistic Infections, 1–5 February. Abstract 204, 117
   Google Scholar
• Keiser P Nassar N Kvanli MB et al Long-term impact of highly active antiretroviral therapy on HIV-related health care costs Journal of Acquired Immune Deficiency Syndrome 27 (1) 14 19 2001
   PubMed Web of Science ®Google Scholar
• Le Pen C Rozenbaum W Downs A et al A cost-effectiveness analysis of changes in therapeutic strategies in the treatment of HIV since 1996 Therapy 57 (1) 27 33 2002
   Google Scholar
• Mandalia S Parmar D Fisher M et al Naively changing HAART HIV Medicine 3 (4) 254 262 2002
   PubMedGoogle Scholar
• Marseille , E , Hofmann , PB and Kahn , JG . 2002 . HIV prevention before HAART in sub-Saharan Africa . Lancet , 359 (9320) : 1851 – 1856 .
   PubMed Web of Science ®Google Scholar
• Mole , OL , Ockrim , K and Holodniy , M . 1999 . Decreased medical expenditures for care of HIV-seropositive patients: the impact of highly active antiretroviral therapy at a US Veterans Affairs Medical Center . Pharmacoeconomics , 16 (3) : 307 – 315 .
   PubMed Web of Science ®Google Scholar
• Mouton Y Alfandari S Valette M et al Service des Maladies Infectieuses AIDS 11 (12) F101 F105 1997
   PubMed Web of Science ®Google Scholar
• Opravil M Ledergerber B Furrer H et al Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell Count>350×106/L AIDS 16 (10) 1371 1381 2002
   PubMed Web of Science ®Google Scholar
• Palella FJ Chmiel JS Moorman AC et al Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients AIDS 16 (12) 1617 1626 2002
   PubMed Web of Science ®Google Scholar
• Rana , KZ and Dudley , MN . 1999 . Human immunodeficiency virus protease inhibitors . Pharmacotherapy , 19 (1) : 35 – 59 .
   PubMed Web of Science ®Google Scholar
• Sendi PP Bucher HC Harr T et al Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients AIDS 13 (9) 1115 1122 1999
   PubMed Web of Science ®Google Scholar
• Sendi P Palmer AJ Gafni A et al Highly active antiretroviral therapy: pharmacoeconomic issues in the management of HIV infection Pharmacoeconomics 19 (7) 709 713 2001
   PubMed Web of Science ®Google Scholar
• Steiner , JF , Koepsell , TD , Fihn , ST and Inui , TS . 1988 . A General method of compliance assessment using centralized pharmacy records: description and validation . Medical Care , 26 (8) : 814 – 823 .
   PubMed Web of Science ®Google Scholar
• Valenti , WM . 2001 . Treatment adherence improves outcomes and manages costs . AIDS Reader , 11 (2) : 77 – 80 .
   PubMedGoogle Scholar
• Valenti , WM . 2002 . The HIV pharmacy: managing quality and costs of HIV care . AIDS Reader , 12 (11) : 486 – 488 .
   PubMedGoogle Scholar